Tetratherix Limited (TTX.AX)
ASX · AUD · Healthcare · Biotechnology
A$5.36 (+5.00%) as of
Key statistics
- Market cap
- 284.41M
- Forward P/E
- -41.29
- EPS (TTM)
- -0.19
- Dividend yield
- 0.00%
- 52-week range
- 3.09 – 8.08
- Revenue (TTM)
- 3.86M
- Profit margin
- -241.36%
- Analyst target
- A$6.95
- Volume
- 8.93k
About Tetratherix Limited
Tetratherix Limited engages in biomaterial and regenerative medicine business in Australia and internationally. The company manufactures and commercialize medical devices in the areas of bone regeneration, tissue spacing, tissue regeneration, and precision medicine applications through its Tetramatrix platform technology. Tetratherix Limited was incorporated in 2015 and is based in Alexandria, Australia.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Alexandria, NSW, Australia
- Employees
- 25
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.